Role of plasma homocysteine and lipoprotein (a) in coronary artery disease

被引:5
作者
Barghash, NA
Elewa, SM
Hamdi, EA
Barghash, AA
El Dine, R
机构
[1] Univ Alexandria, Dept Med Biochem, Alexandria, Egypt
[2] Univ Alexandria, Dept Cardiol & Angiol, Fac Med, Alexandria, Egypt
关键词
coronary disease; folic acid; homocysteine; lipoprotein(a); plasminogen activator inhibitor-1;
D O I
10.1080/09674845.2004.11732648
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
This study looks at the possible role of some nontraditional risk factors for premature coronary artery disease (CAD) and assesses the presence of relationship between these factors and the traditional cardiovascular risk factors. The study subjects (n=45) are divided into three groups comprising 15 premature CAD patients without traditional cardiovascular risk factors (group I); 15 premature CAD patients with one or more traditional cardiovascular risk factors (group II); and 15 healthy normal control subjects matched for age and sex (group III). Estimation of plasma homocysteine (Hcy) and plasminogen activator inhibitor-1 (PAI-1) is performed by enzyme-linked immunosorbent assay (ELISA); plasma folic acid by radioimmunoassay; plasma lipoprotein a (Lpa) by turbidimetry; and plasma lipids by colorimetry. Results showed a significant association between elevated Hcy and low folate levels and premature CAD in both patient groups. Also, a significant association was seen between elevated PAI-1 and CAD in the two patient groups, and between CAD and high levels of Hcy and triglycerides, as well as a low level of high-density lipoprotein cholesterol. Lpa showed significant association with premature CAD only in group II. Thus, Hcy, folic acid and PAI-1 might serve as independent risk factors for premature CAD in patients both with and without traditional coronary risk factors. However, Lpa might confer an additional coronary risk factor only in the presence of traditional risk factors.
引用
收藏
页码:78 / 83
页数:6
相关论文
共 43 条
  • [1] Relationships between homocysteine, Factor VIIa, and thrombin generation in acute coronary syndromes
    Al-Obaidi, MK
    Philippou, H
    Stubbs, PJ
    Adami, A
    Amersey, R
    Noble, MM
    Lane, DA
    [J]. CIRCULATION, 2000, 101 (04) : 372 - 377
  • [2] ALLAIN CC, 1974, CLIN CHEM, V20, P470
  • [3] ALLEN RH, 1995, CLIN HEMOST REV, V9, P9
  • [4] Methylenetetrahydrofolate reductase gene C677T polymorphism, homocysteine, vitamin B12, and DNA damage in coronary artery disease
    Andreassi, MG
    Botto, N
    Cocci, F
    Battaglia, D
    Antonioli, E
    Masetti, S
    Manfredi, S
    Colombo, MG
    Biagini, A
    Clerico, A
    [J]. HUMAN GENETICS, 2003, 112 (02) : 171 - 177
  • [5] Atherogenic, hemostatic, and other potential risk markers in subjects with previous isolated myocardial infarction compared with long-standing uncomplicated stable angina
    Bogaty, P
    Robitaille, NM
    Solymoss, S
    Boyer, L
    Auger, D
    Labbé, L
    Simard, S
    Rail, J
    Genest, J
    Turgeon, J
    [J]. AMERICAN HEART JOURNAL, 1998, 136 (05) : 884 - 893
  • [6] ENZYMATIC DETERMINATION OF TRIGLYCERIDE, FREE-CHOLESTEROL, AND TOTAL CHOLESTEROL IN TISSUE LIPID EXTRACTS
    CARR, TP
    ANDRESEN, CJ
    RUDEL, LL
    [J]. CLINICAL BIOCHEMISTRY, 1993, 26 (01) : 39 - 42
  • [7] Acute hyperhomocysteinaemia and endothelial dysfunction
    Chambers, JC
    McGregor, A
    Jean-Marie, J
    Kooner, JS
    [J]. LANCET, 1998, 351 (9095) : 36 - 37
  • [8] Cheitlin MD, 1993, CLIN CARDIOL, P147
  • [9] CHEN IW, 1982, CLIN CHEM, V28, P2161
  • [10] Conri C, 2000, PRESSE MED, V29, P737